SCHEMBL3763758

SCHEMBL3763758

Cc1nc2c(F)c(Br)ccc2n1C(=O)OCC(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ASAH1 Q13510 2/20 0.36
P2RX4 Q99571 1/20 0.34
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
BRD4 O60885 3/20 0.33
TSHR P16473 3/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
HPGD P15428 1/20 0.32
SCN9A Q15858 1/20 0.31
SCN10A Q9Y5Y9 1/20 0.31
ACACB O00763 1/20 0.31
GAA P10253 2/20 0.31
KDM4E B2RXH2 1/20 0.31
GLA P06280 1/20 0.31
CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL861356 0.79 NR1H2 (0.35)
SCHEMBL862091 0.77 ALDH1A1 (0.39) ALDH1A1NPC1RAB9AASAH1P2RX4
SCHEMBL861097 0.76 ALDH1A1 (0.38) ALDH1A1NPC1RAB9AASAH1P2RX4
SCHEMBL8539342 0.73 ALDH1A1 (0.45) ALDH1A1NPC1RAB9AASAH1P2RX4
SCHEMBL855641 0.72 ALDH1A1 (0.37) ALDH1A1NPC1RAB9AASAH1P2RX4
SCHEMBL861881 0.66 ALDH1A1 (0.43) ALDH1A1NPC1RAB9AP2RX4LMNA
SCHEMBL859022 0.65 ALDH1A1 (0.39) ALDH1A1NPC1RAB9AASAH1P2RX4
SCHEMBL2373630 0.65 GPR119 (0.43) NPC1RAB9AP2RX4KMT2AMEN1
SCHEMBL2034906 0.64 SIK1 (0.42) ALDH1A1NPC1RAB9AASAH1P2RX4
SCHEMBL14720210 0.63 NTSR1 (0.46) ALDH1A1NPC1RAB9AP2RX4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140107100-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-04-17 US disclosed
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-03-20 US disclosed
US-8648066-B2 Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture EXELIXIS, INC. (US) 2014-02-11 US disclosed
EP-2640366-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE Exelixis, Inc. (US) 2013-09-25 EP disclosed
WO-2012068096-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2012-05-24 WO disclosed
US-20100298290-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298290-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA ALDH1A1 3395/4885NPC1 1583/4885RAB9A 1023/4885
US-20140107100-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA ALDH1A1 3533/4885NPC1 1273/4885RAB9A 720/4885
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA ALDH1A1 3049/4885NPC1 1132/4885RAB9A 1064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.